ORCID as entered in ROS

Select Publications
2024, 'Restricting supply of tobacco products to pharmacies: A scoping review', Tobacco Control, http://dx.doi.org/10.1136/tc-2023-058486
,2024, 'The use of wastewater based epidemiology to detect synthetic opioids in the community', BMJ, http://dx.doi.org/10.1136/bmj.q5
,2024, 'What is the hype on #MedicinalCannabis in the United States? A content analysis of medicinal cannabis tweets', Drug and Alcohol Review, 43, pp. 28 - 35, http://dx.doi.org/10.1111/dar.13618
,2023, 'A provisional evaluation of Australia's medical cannabis program', International Journal of Drug Policy, 122, http://dx.doi.org/10.1016/j.drugpo.2023.104210
,2023, 'How has the brain disease model of addiction contributed to tobacco control?', Drug and Alcohol Dependence, 253, http://dx.doi.org/10.1016/j.drugalcdep.2023.111033
,2023, 'Legal sourcing of ten cannabis products in the Canadian cannabis market, 2019–2021: a repeat cross-sectional study', Harm Reduction Journal, 20, http://dx.doi.org/10.1186/s12954-023-00753-6
,2023, 'Outcomes associated with nonmedical cannabis legalization policy in Canada: Taking stock at the 5-year mark', CMAJ Canadian Medical Association Journal, 195, pp. E1648 - E1650, http://dx.doi.org/10.1503/cmaj.230808-f
,2023, 'Efficacy of smokeless tobacco for smoking cessation: A systematic review and meta-analysis', Tobacco Control, 32, pp. 757 - 768, http://dx.doi.org/10.1136/tobaccocontrol-2021-057019
,2023, 'Longitudinal association between exposure to e-cigarette advertising and youth e-cigarette use in the United States', Addictive Behaviors, 146, http://dx.doi.org/10.1016/j.addbeh.2023.107810
,2023, 'The implementation and public health impacts of cannabis legalization in Canada: a systematic review', Addiction, 118, pp. 2062 - 2072, http://dx.doi.org/10.1111/add.16274
,2023, 'Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark', CMAJ Canadian Medical Association Journal, 195, pp. E1351 - E1353, http://dx.doi.org/10.1503/cmaj.230808
,2023, 'Assessing the effects of COVID-19 restrictions on alcohol consumption in Melbourne, Australia using high-resolution wastewater sampling', Science of the Total Environment, 893, http://dx.doi.org/10.1016/j.scitotenv.2023.164846
,2023, 'Monitoring medication and illicit drug consumption in a prison by wastewater-based epidemiology: Impact of COVID-19 restrictions', Water Research, 244, http://dx.doi.org/10.1016/j.watres.2023.120452
,2023, 'Will Germany's new cannabis policy reform plans serve public health?', European Journal of Public Health, 33, pp. 753 - 754, http://dx.doi.org/10.1093/eurpub/ckad077
,2023, 'All-cause and cause-specific mortality in individuals with an alcohol-related emergency or hospital inpatient presentation: A retrospective data linkage cohort study', Addiction, 118, pp. 1751 - 1762, http://dx.doi.org/10.1111/add.16218
,2023, 'Minimizing double standards in assessing the adverse and beneficial effects of cannabis', Addiction, 118, pp. 1606 - 1608, http://dx.doi.org/10.1111/add.16267
,2023, 'Global prevalence of heated tobacco product use, 2015–22: A systematic review and meta-analysis', Addiction, 118, pp. 1430 - 1444, http://dx.doi.org/10.1111/add.16199
,2023, 'Risk-thresholds for the association between frequency of cannabis use and the development of psychosis: A systematic review and meta-analysis', Psychological Medicine, 53, pp. 3858 - 3868, http://dx.doi.org/10.1017/S0033291722000502
,2023, 'Cannabis Use and Health-Related “Harm to Others”: Toward a Conceptual Framework and Evidence Base for Public Health', Journal of Studies on Alcohol and Drugs, 84, pp. 636 - 643, http://dx.doi.org/10.15288/jsad.22-00388
,2023, 'Cannabis use in sub-Saharan Africa: A systematic review and meta-analysis', Addiction, 118, pp. 1201 - 1215, http://dx.doi.org/10.1111/add.16170
,2023, 'Common adverse events of electronic cigarettes compared with traditional nicotine replacement therapies: A systematic review and meta-analysis', Drug and Alcohol Review, 42, pp. 1278 - 1287, http://dx.doi.org/10.1111/dar.13674
,2023, 'How should nicotine vaping be regulated in Australia?', Drug and Alcohol Review, 42, pp. 1288 - 1294, http://dx.doi.org/10.1111/dar.13663
,2023, 'Response to commentaries on proposed regulation of nicotine vaping', Drug and Alcohol Review, 42, pp. 1301 - 1302, http://dx.doi.org/10.1111/dar.13667
,2023, 'What are the harms of vaping in young people who have never smoked?', International Journal of Drug Policy, 117, http://dx.doi.org/10.1016/j.drugpo.2023.104064
,2023, 'A critique of the Australian National Health and Medical Research Council CEO statement on electronic cigarettes', Addiction, 118, pp. 1184 - 1192, http://dx.doi.org/10.1111/add.16143
,2023, 'Do not let the ideal be the enemy of good enough regulation', Addiction, 118, pp. 1009 - 1010, http://dx.doi.org/10.1111/add.16201
,2023, 'How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?', Addiction, 118, pp. 998 - 1003, http://dx.doi.org/10.1111/add.16135
,2023, 'A latent class analysis of patterns of tobacco and cannabis use in Australia and their health-related correlates', Drug and Alcohol Review, 42, pp. 815 - 826, http://dx.doi.org/10.1111/dar.13614
,2023, 'The use of asthma and allergy medicines is associated with exposure to smoking', Nature Water, 1, pp. 443 - 450, http://dx.doi.org/10.1038/s44221-023-00076-7
,2023, 'Wastewater-based monitoring could help guide responses to the USA opioid epidemic', Nature Water, 1, pp. 401 - 404, http://dx.doi.org/10.1038/s44221-023-00082-9
,2023, 'A wastewater-based evaluation of the effectiveness of codeine control measures in Australia', Addiction, 118, pp. 480 - 488, http://dx.doi.org/10.1111/add.16083
,2023, 'Vaping on TikTok: a systematic thematic analysis', Tobacco Control, 32, pp. 251 - 254, http://dx.doi.org/10.1136/tobaccocontrol-2021-056619
,2023, 'How May Cannabis Legalization Affect the Adverse Health Effects of Cannabis?', Sucht, 69, pp. 12 - 14, http://dx.doi.org/10.1024/0939-5911/a000800
,2023, 'Nicotine vaping was not the cause of e-cigarette, or vaping, product use-associated lung injury in the United States', Drug and Alcohol Review, 42, pp. 258 - 261, http://dx.doi.org/10.1111/dar.13533
,2023, 'Trends in cannabis use intention around the period of cannabis legalisation in Australia: An age-period-cohort model', Drug and Alcohol Review, 42, pp. 337 - 345, http://dx.doi.org/10.1111/dar.13578
,2023, 'National Wastewater Reconnaissance of Analgesic Consumption in Australia', Environmental Science and Technology, 57, pp. 1712 - 1720, http://dx.doi.org/10.1021/acs.est.2c06691
,2023, 'Nation-Wide Wastewater-Based Epidemiology Assessment of Metformin Usage in China: 2014-2020', ACS Es and T Water, 3, pp. 195 - 202, http://dx.doi.org/10.1021/acsestwater.2c00489
,2023, 'Minimizing policy-biased appraisals of the evidence on cannabis and psychosis', Frontiers in Psychiatry, 13, http://dx.doi.org/10.3389/fpsyt.2022.1047860
,2023, 'Avoiding the Premature Introduction of Psychedelic Medicines in Alzheimer’s Disease and Related Disorders', AJOB Neuroscience, 14, pp. 129 - 131, http://dx.doi.org/10.1080/21507740.2023.2188287
,2023, 'Benefits and risks of cannabinoids', BMJ, http://dx.doi.org/10.1136/bmj.p2113
,2023, 'Die ‘Richtlinien für die Risiko-Reduzierung beim Cannabiskonsum (RRRCK)’: EMPFEHLUNGEN [The ‘Lower-Risk Cannabis Use Guidelines (LRCUG)’: RECOMMENDATIONS (GERMAN)]', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2023.103995
,2023, 'Illicit drug use and violence', , 197, pp. 121 - 145, http://dx.doi.org/10.1016/B978-0-12-821375-9.00010-4
,2023, 'Las ‘Guías para el Uso de Cannabis de Menor Riesgo (GUCMR)’: RECOMENDACIONES [The ‘Lower-Risk Cannabis Use Guidelines (LRCUG)’: RECOMMENDATIONS (SPANISH)]', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2023.103996
,2023, 'Les ‘Lignes Directrices Pour l'Usage du Cannabis à Moindre Risque (LUCMR)’: RECOMMENDATIONS [The ‘Lower-Risk Cannabis Use Guidelines (LRCUG)’: RECOMMENDATIONS (FRENCH)]', International Journal of Drug Policy, http://dx.doi.org/10.1016/j.drugpo.2023.103994
,2023, 'Recommendations for Reducing the Risk of Cannabis Use-Related Adverse Psychosis Outcomes: A Public Mental Health-Oriented Evidence Review', Journal of Dual Diagnosis, 19, pp. 71 - 96, http://dx.doi.org/10.1080/15504263.2023.2226588
,2023, 'Use of flavored cannabis vaping products in the US, Canada, Australia, and New Zealand: findings from the international cannabis policy study wave 4 (2021)', American Journal of Drug and Alcohol Abuse, 49, pp. 640 - 651, http://dx.doi.org/10.1080/00952990.2023.2238116
,2022, 'Effectiveness, safety and cost-effectiveness of vaporized nicotine products versus nicotine replacement therapy for tobacco smoking cessation in a low-socioeconomic status Australian population: a study protocol for a randomized controlled trial', Trials, 23, http://dx.doi.org/10.1186/s13063-022-06644-8
,2022, 'Germany's evolving framework for cannabis legalization and regulation: Select comments based on science and policy experiences for public health', Lancet Regional Health Europe, 23, http://dx.doi.org/10.1016/j.lanepe.2022.100546
,2022, 'The 1964 US Surgeon General's report on smoking and health', Addiction, 117, pp. 3170 - 3175, http://dx.doi.org/10.1111/add.16007
,2022, 'Tobacco and nicotine use', Nature Reviews Disease Primers, 8, http://dx.doi.org/10.1038/s41572-022-00346-w
,